News - Gastro-intestinals


Current filters:


Popular Filters

64 to 88 of 187 results

Helsinn and Zealand to advance elsiglutide for chemotherapy-induced diarrhea prevention


Privately-held Swiss pharmaceutical group Helsinn and its partner, Denmark-based Zealand Pharma A/S (Nasdaq:…

elsiglutideGastro-intestinalsHelsinnOncologyPharmaceuticalResearchZealand Pharma

US FDA approves Janssen's Simponi to treat ulcerative colitis


The US Food and Drug Administration late yesterday (May 15) approved a new use for Johnson & Johnson…

BiotechnologyGastro-intestinalsInflammatory diseasesJanssen BiotechJohnson & JohnsonNorth AmericaPharmaceuticalRegulationSimponi Injection

AbbVie and Alvine link up on investigational oral therapy for celiac disease


US drugmaker AbbVie (NYSE: ABBV) and privately-held Alvine Pharmaceuticals, a leader in celiac disease…

AbbVieALV003Alvine PharmaceuticalsGastro-intestinalsLicensingPharmaceuticalResearch

Shire prevails in US Lialda patent dispute with Watson


Ireland-headquartered drugmaker Shire's (LSE: SHP) subsidiary Shire Development has prevailed in its…

ActavisGastro-intestinalsGenericsLegalLialdaNorth AmericaPatentsPharmaceuticalShireWatson Pharmaceuticals

Vedolizumab has potential to offer improvement over infliximab in UC


Surveyed US and EU5 gastroenterologists agree that new moderate to severe ulcerative colitis (UC) therapies…

EuropeGastro-intestinalsinfliximabJanssenMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRemicadeTakeda Pharmaceuticalsvedolizumab

Positive Ph IIb results for SALVAT's tarafenacin in overactive bladder


Spanish drugmaker Laboratorios SALVAT and its South Koran partner Kwang Dong Pharmaceutical have released…

Gastro-intestinalsKwang Dong PharmaceuticalLaboratorios SALVATLicensingPharmaceuticalResearchtarafenacin

FDA approves Eisai's Aciphex Sprinkle for GERD in children; Inovelon OKed in Japan


Japanese drug major Eisai (TYO: 4523) says that the US Food and Drug Administration has approved Aciphex…

AciphexAsia-PacificEisaiGastro-intestinalsInovelonNeurologicalNorth AmericaPharmaceuticalRegulation

Zeria and Astellas' Acofide approved in Japan for functional dyspepsia


Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the marketing of Acofide (acotiamide…

AcofideAsia-PacificAstellas PharmaGastro-intestinalsPharmaceuticalRegulationZeria Pharmaceuticals

NPS Pharma regains rights to Revestive and Preotact from Takeda


USA-based NPS Pharmaceuticals (Nasdaq: NPSP) has re-gained the full worldwide rights from partner Takeda…

Anti-Arthritics/RheumaticsGastro-intestinalsGattexLicensingNatparaNPS PharmaceuticalsPharmaceuticalPreotactRevestiveTakeda Pharmaceuticals

Eisai slams German decision on Fycompa; Takeda files vedolizumab with EMA


The German Federal Joint Committee (G-BA), the decision-making body of the self-governing medical system…

EisaiEuropeFycompaGastro-intestinalsNeurologicalPharmaceuticalRegulationTakeda Pharmaceuticalsvedolizumab

US gastroenterologists increasingly using biologics to treat Crohn's patients in remission


Although there have been no significant changes with regard to biologic treatment and Crohn's disease…

AbbVieBiotechnologyCimziaGastro-intestinalsHumiraJanssenMarkets & MarketingNorth AmericaPharmaceuticalRemicadeUCB

Merck Serono spins out sixth company - Calypso Biotech - to focus on gastrointestinal immunological disorders


German drug major Merck KGaA's (MRK: DE) subsidiary Merck Serono yesterday (March 4) announced the creation…

BiotechnologyCalypso BiotechGastro-intestinalsInflammatory diseasesMerck KGaAMerck SeronoMergers & Acquisitions

Astellas starts European roll-out of OAB drug Betmiga in UK


The European subsidiary of Japanese drug major Astellas Pharma (TYO: 4503) has started the European launch…

Astellas PharmaBetmigaEuropeGastro-intestinalsMarkets & MarketingPharmaceutical

Encouraging results for AstraZeneca's naloxegol in OIC


Anglo-Swedish drug major AstraZeneca (LSE: AZN) has announced high-level results from KODIAC-08, an open-label,…


Lexicon Pharma updates on clinical pipeline


US drug developer Lexicon Pharmaceutical (Nasdaq: LXRX) yesterday updated its drug development pipeline,…

BiotechnologyDiabetesGastro-intestinalsLexicon PharmaceuticalsLX1032LX1033LX4211OncologyResearchtelotristat etiprate

Positive Ph III results for AbbVie's Humira in pediatric Crohn's disease; five leukemia studies suspended


AbbVie (NYSE: ABBV), the new spin-out from Abbott Laboratories, has announced the first long-term, patient-reported…

Abbott LaboratoriesAbbVieAnti-Arthritics/RheumaticsGastro-intestinalsHumiraOncologyPharmaceuticalResearch

Launch of Ipsen/Braintree's Eziclen/Izinova in Europe expected by end 2013


French drugmaker Ipsen (Euronext: IPN) and US partner Braintree Laboratories yesterday announced today…

Braintree LaboratoriesEuropeEziclenGastro-intestinalsIpsenIzinovaPharmaceuticalRegulation

FDA approves first anti-diarrheal drug for HIV/AIDS patient, Salix Pharma's Fulyzaq


Continuing the flurry of 2012 year-end drug approvals, the US Food and Drug Administration on Monday…

crofelemerFulyzaqGastro-intestinalsNapo PharmaceuticalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

FDA approvals for Gattex, Adasuve, Varizig and Tamiflu


Ahead of the Christmas holiday period, the US Food and Drug Administration announced a number of regulatory…

Anti-viralsBiotechnologyGastro-intestinalsNeurologicalNorth AmericaPharmaceuticalRegulation

Phenex in up to $135 million research collaboration with Janssen


Privately-held German drug discovery firm Phenex Pharmaceuticals has entered into an agreement with Janssen…

Anti-Arthritics/RheumaticsBiotechnologyGastro-intestinalsInflammatory diseasesJanssenJohnson & JohnsonLicensingPhenex PharmaceuticalsResearch

64 to 88 of 187 results

Back to top